A new competing drug has entered the 'Zytiga' generic market, where Hanmi Pharmaceutical was the only company to launch a product last year.

Ace Pharmaceutical has introduced a drug imported from India to the South Korean market.

While Hanmi Pharmaceutical is strengthening its market presence by recently launching a combination drug, the new generic entry garners attention due to its impact on market competition.

According to industry sources on August 25th, Ace Pharmaceutical listed 'Aviron Tab 500 mg (abiraterone acetate)' for reimbursement.

The drug has the same active ingredient as Janssen Korea's Zytiga. Zytiga is an anticancer used in treatin